Clinical Trial Stage Funding Opportunities
Opportunities for CLIN funding are currently closed.
CLIN 1: Late Stage Preclinical Projects
CLIN 2: Clinical Trial Stage Projects
Objective
The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. With this initiative, we intend to speed up support for clinical stage candidate stem cell treatments that demonstrate scientific excellence. Under this initiative, we will provide funding for eligible projects that are completing late stage preclinical development through any stage of clinical trial activity.
- July 2024 – Public Memo: CLIN 1 & CLIN 2 Program Updated Review Process (PDF)
- CLIN 1 & CLIN 2 Updated Review Process FAQ (PDF)
- CLIN 1: Funding Opportunity for Late Stage Preclinical Projects (PDF: updated 07.03.24)
- CLIN 2: Funding Opportunity for Clinical Trial Stage Projects (PDF: updated 07.03.24)
CLIN 4: Late Stage Development Projects
Objective
With this initiative, we intend to speed up support late-stage clinical candidate stem cell and genetic therapy treatments to Biologics License Application (BLA) readiness.
Effective immediately, CIRM is establishing an open call for proposals and will accept applications monthly for the late-stage development CLIN4 award type described in the Program Announcement listed below.
- CLIN 4: Funding Opportunity for Late Stage Development Projects [pdf] (Updated 4.24.24)
For previous versions of the CLIN Program Announcements, please refer to our Previous Funding Opportunities page.